Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Neuroprotective Effects of ACTH4-10Pro8-Gly9-Pro10 in Neonatal Rats
NCT05648526Completed
- Sponsor
- Universitas Sumatera Utara
- Start
- Aug 2021
- Primary completion
- Sep 2021
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
Randomised trial of semax in neurotoxicity (2 arms), sponsored by Universitas Sumatera Utara. Primary endpoints: BDNF Expression in Cortex and Hippocampus at 6 hours and BDNF Serum Concentrations at 6 hours. Started Aug 2021; status: completed.
02
Drugs
semax
03
Conditions
neurotoxicity
Beyond the preview
Go deeper on NCT05648526.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05648526.